Chugai settles cancer drug patent dispute with US firm

Parties to withdraw lawsuit over lung cancer drug | ANDA generic would have displaced sales of patented version in Delaware, said plaintiff.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Drugs to Watch report: 15 blockbusters for 2023

12 January 2023 Clarivate study highlights treatments with blockbuster potential | IV, Parkinson’s disease, Crohn’s disease, alopecia, multiple myeloma and breast cancer make the list | Nine blockbusters from China also predicted.

Americas

Court delivers split ruling in lung drug dispute

1 September 2022 Lengthy opinion invalidated plaintiff’s patent but ruled that defendant’s would still infringe | Patents at issue related to treatment for high blood pressure in the lungs.

Big Pharma

Teva settles patent dispute with Aurobindo

13 June 2022 Israel-headquartered Teva has settled its dispute with Indian generic maker Aurobindo over a drug used to treat Huntington’s disease.

More on this story

Big Pharma

Drugs to Watch report: 15 blockbusters for 2023

Americas

Court delivers split ruling in lung drug dispute

1 September 2022 Lengthy opinion invalidated plaintiff’s patent but ruled that defendant’s would still infringe | Patents at issue related to treatment for high blood pressure in the lungs.

Big Pharma

Teva settles patent dispute with Aurobindo

13 June 2022 Israel-headquartered Teva has settled its dispute with Indian generic maker Aurobindo over a drug used to treat Huntington’s disease.

More on this story

Big Pharma

Drugs to Watch report: 15 blockbusters for 2023

Americas

Court delivers split ruling in lung drug dispute

1 September 2022 Lengthy opinion invalidated plaintiff’s patent but ruled that defendant’s would still infringe | Patents at issue related to treatment for high blood pressure in the lungs.

Big Pharma

Teva settles patent dispute with Aurobindo

13 June 2022 Israel-headquartered Teva has settled its dispute with Indian generic maker Aurobindo over a drug used to treat Huntington’s disease.